HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alexander Baraniskin Selected Research
Alexander Baraniskin Research Topics
Disease
12
Lymphoma (Lymphomas)
04/2024 - 09/2010
11
Neoplasms (Cancer)
04/2024 - 03/2011
8
Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 03/2011
3
Residual Neoplasm
04/2024 - 01/2014
2
Hematologic Neoplasms (Hematological Malignancy)
12/2021 - 01/2021
2
B-Cell Lymphoma (Lymphoma, B Cell)
05/2018 - 09/2010
2
Lung Neoplasms (Lung Cancer)
04/2016 - 03/2016
2
Adenocarcinoma
07/2014 - 01/2013
1
Stomach Neoplasms (Stomach Cancer)
11/2023
1
Neoplasm Micrometastasis
01/2023
1
Virus Diseases (Viral Diseases)
01/2021
1
COVID-19
01/2021
1
Pneumonia (Pneumonitis)
01/2021
1
Rectal Neoplasms (Rectal Cancer)
01/2021
1
Multiple Myeloma
01/2020
1
Hematologic Diseases (Blood Diseases)
10/2019
1
Pathologic Complete Response
01/2019
1
Infections
01/2019
1
Vision Disorders (Hemeralopia)
11/2017
1
Cholangiocarcinoma
07/2014
1
Sclerosing Cholangitis
07/2014
1
Ovarian Neoplasms (Ovarian Cancer)
01/2014
1
Ovarian Epithelial Carcinoma
01/2014
1
Subdural Hematoma (Subdural Hemorrhage)
01/2014
1
Multiple Sclerosis
11/2012
1
Colonic Neoplasms (Colon Cancer)
04/2012
1
Carcinogenesis
01/2012
1
Glioma (Gliomas)
01/2012
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2011
1
Nervous System Diseases (Neurological Disorders)
09/2010
1
Hemolysis
01/2010
1
Anemia
01/2010
Drug/Important Bio-Agent (IBA)
13
Biomarkers (Surrogate Marker)
IBA
04/2024 - 03/2011
8
MicroRNAs (MicroRNA)
IBA
01/2017 - 03/2011
5
U2 small nuclear RNA (U2 snRNA)
IBA
04/2016 - 01/2013
3
Circulating Tumor DNA
IBA
01/2023 - 01/2017
3
DNA (Deoxyribonucleic Acid)
IBA
12/2021 - 01/2017
2
axicabtagene ciloleucel
IBA
12/2021 - 01/2021
2
Chimeric Antigen Receptors
IBA
12/2021 - 01/2021
2
Methotrexate (Mexate)
FDA Link
Generic
01/2020 - 01/2019
2
Small Nuclear RNA (snRNA)
IBA
01/2014 - 01/2013
1
Steroids
IBA
04/2024
1
trastuzumab deruxtecan
IBA
11/2023
1
human ERBB2 protein
IBA
11/2023
1
Monoclonal Antibodies
IBA
11/2023
1
Trastuzumab (Herceptin)
FDA Link
11/2023
1
Platinum
IBA
11/2023
1
Immunoconjugates (Immunoconjugate)
IBA
11/2023
1
Cell-Free Nucleic Acids
IBA
12/2021
1
Oxygen (Dioxygen)
IBA
01/2021
1
Bevacizumab (Avastin)
FDA Link
01/2019
1
Retinaldehyde (Retinal)
IBA
11/2017
1
Formaldehyde (Formol)
FDA Link
01/2017
1
Emulsions
IBA
01/2017
1
Paraffin
IBA
01/2017
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2012
1
RNA (Ribonucleic Acid)
IBA
03/2011
1
Fluorouracil (Carac)
FDA Link
Generic
03/2011
1
Peptides (Polypeptides)
IBA
03/2011
1
Capecitabine (Xeloda)
FDA Link
03/2011
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
03/2011
1
Immunoglobulin lambda-Chains
IBA
09/2010
1
Immunoglobulin Light Chains (Immunoglobulin Light Chain)
IBA
09/2010
1
Oxidoreductases (Dehydrogenase)
IBA
01/2010
Therapy/Procedure
10
Therapeutics
11/2023 - 03/2011
9
Drug Therapy (Chemotherapy)
11/2023 - 03/2011
2
Hematopoietic Stem Cell Transplantation
01/2020 - 10/2019
1
Blood Component Removal (Apheresis)
01/2021
1
Neoadjuvant Therapy
01/2021
1
Combination Drug Therapy (Combination Chemotherapy)
01/2020
1
Stem Cell Transplantation
01/2019